Table 4.

Relationship between clinic-pathological parameters and serum levels of resistin, adiponectin, and apelin in GEC patients.

	Resistin (ng/mL)		Adiponectin (μg/mL)		Apelin (pg/mL)
	mean ± SD	P	mean ± SD	P	mean ± SD	P
Histological type		0.495		0.277		0.065
scc (n = 39)	10.9 ± 3.3		9.02 ± 4.33		886 ± 127
adca (n = 46)	10.4 ± 3.4		8.08 ± 3.59		836 ± 118
TNM stage		0.223		0.260		0.381
II (n = 10)	9.2 ± 3.3		9.3 ± 3.8		889 ± 117
III (n = 27)	10.7 ± 2.7		7.9 ± 4.8		818 ± 176
IV (n = 48)	11.2 ± 3.6		7.2 ± 2.5		862 ± 199
Tumor stage (T)		0.330		0.484		0.231
T2 (n = 11)	9.1 ± 3.3		8.8 ± 3.7		801 ± 135
T3 (n = 22)	9.9 ± 3.6		8.3 ± 6.4		828 ± 160
T4 (n = 52)	11.1 ± 3.2		7.4 ± 1.2		891 ± 154
Lymph node metastasis		0.142		0.012∗		0.104
N0 (n = 26)	10.2 ± 2.9		9.5 ± 3.7		821 ± 146
N1 (n = 59)	11.3 ± 3.7		7.4 ± 3.8		865 ± 101
Distant metastasis		<0.001∗		0.037∗		0.106
M0 (n = 38)	9.6 ± 3.1		9.5 ± 4.1		836 ± 152
M1 (n = 47)	12.2 ± 3.2		7.7 ± 3.6		881 ± 101

Data analyzed using one-way ANOVA or t-test for independent samples. scc: squamous cell carcinoma; adca: adenocarcinoma; *statistically significant.